PMID- 29735975 OWN - NLM STAT- MEDLINE DCOM- 20180928 LR - 20181114 IS - 1643-3750 (Electronic) IS - 1234-1010 (Print) IS - 1234-1010 (Linking) VI - 24 DP - 2018 May 8 TI - Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients. PG - 2919-2927 LID - 10.12659/MSM.909712 [doi] AB - BACKGROUND Chemotherapy can cause adverse effects such as chemotherapy-related cognitive impairment (CRCI). In this prospective study, the efficacy of traditional Chinese medicine acupuncture therapy in relieving CRCI and its impact on serum brain-derived neurotrophic factor (BDNF) are evaluated. MATERIAL AND METHODS Eighty patients were randomly divided into a treatment group and a control group with 40 patients in each group. The treatment group was treated at the following acupuncture points: Baihui (DU20), Sishencong (EX-HN1), Shenting (DU24), Zusanli (ST36), Taixi (K13), Dazhong (K14), and Juegu (GB39). Cognitive function was assessed using the functional assessment of cancer treatment cognition test (FACT-COG, version 3), the auditory-verbal learning test (AVLT), the verbal fluency test (VFT), the symbol digit modality test (SDMT), the clock-drawing test (CDT), and the trail-making test part B (TMT-B). In addition, blood serum levels of BDNF were measured before and after treatment. Correlations between change in BDNF levels and cognitive function were also analyzed. RESULTS CRCI was ameliorated in the acupuncture treatment group, with scores on FACT-COG, AVLT-recognition and CDT assessments all significantly increased (P<0.05 in all cases). In addition, serum BDNF levels after acupuncture treatment were significantly higher than before treatment ([i]t[/i]=3.242, [i]P[/i]<0.01). Moreover, the level of BDNF was positively correlated with the total score of FACT-COG, AVLT-recognition, and CDT ([i]r[/i]=0.694, 0.628, and 0.532, respectively; all P<0.05). The control group showed no statistically significant difference in any measures over the same period. CONCLUSIONS Acupuncture therapy is effective in the treatment of CRCI in breast cancer patients through a mechanism that may be related to an increase of BDNF. FAU - Tong, Taishan AU - Tong T AD - Department of Psychology and Psychiatry, The Affiliated Wuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu, China (mainland). FAU - Pei, Chunqin AU - Pei C AD - Department of Acupuncture and Moxibustion, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China (mainland). FAU - Chen, Jun AU - Chen J AD - Department of Acupuncture and Moxibustion, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China (mainland). FAU - Lv, Qing AU - Lv Q AD - Department of Breast Surgery, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China (mainland). FAU - Zhang, Fuquan AU - Zhang F AD - Department of Psychology and Psychiatry, The Affiliated Wuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu, China (mainland). FAU - Cheng, Zaohuo AU - Cheng Z AD - Department of Psychology and Psychiatry, The Affiliated Wuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu, China (mainland). LA - eng PT - Clinical Trial PT - Journal Article DEP - 20180508 PL - United States TA - Med Sci Monit JT - Medical science monitor : international medical journal of experimental and clinical research JID - 9609063 RN - 0 (Antineoplastic Agents) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 7171WSG8A2 (BDNF protein, human) SB - IM MH - *Acupuncture Therapy MH - Antineoplastic Agents/pharmacology/*therapeutic use MH - Brain-Derived Neurotrophic Factor/blood MH - Breast Neoplasms/blood/*complications/*drug therapy/psychology MH - Cognitive Dysfunction/blood/*etiology/psychology/*therapy MH - Demography MH - Female MH - Humans MH - Middle Aged MH - Neuropsychological Tests MH - Treatment Outcome PMC - PMC5963738 OTO - NOTNLM OT - Acupuncture - methods OT - Brain-Derived Neurotrophic Factor - chemical synthesis OT - Breast OT - mild cognitive impairment EDAT- 2018/05/08 06:00 MHDA- 2018/10/03 06:00 PMCR- 2018/05/08 CRDT- 2018/05/09 06:00 PHST- 2018/05/09 06:00 [entrez] PHST- 2018/05/08 06:00 [pubmed] PHST- 2018/10/03 06:00 [medline] PHST- 2018/05/08 00:00 [pmc-release] AID - 909712 [pii] AID - 10.12659/MSM.909712 [doi] PST - epublish SO - Med Sci Monit. 2018 May 8;24:2919-2927. doi: 10.12659/MSM.909712.